Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2022

View Archived Issues

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Machine learning approach speeds resistance identification

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Celgene presents new cereblon-binding PROTACs

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Viral replication inhibitors patented by Gilead

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer

Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection

Vir expands partnership with Gates Foundation in HIV and malaria

Preclinical data confirm anticancer activity of two lead compounds in Captor's CT-01 program in HCC

Novel genes identified with risk of obsessive-compulsive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....